JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 9 September 2008

Journal of Endocrinology 2008;199:445.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0226
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0226v1
199/3/445    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, M.
Right arrow Articles by Doihara, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, M.
Right arrow Articles by Doihara, H.

RESEARCH

Bone morphogenetic protein (BMP)-6 and BMP-7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 MAPK activation

Mina Takahashi, Fumio Otsuka, Tomoko Miyoshi, Hiroyuki Otani, Junko Goto, Misuzu Yamashita, Toshio Ogura, Hirofumi Makino and Hiroyoshi Doihara

M Takahashi, Cancer and Thoracic Surgery, Okayama University Graduate School, Okayama, Japan
F Otsuka, Medicine and Clinical Science, Okayama University Graduate School, Okayama-city, 700-8558, Japan
T Miyoshi, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
H Otani, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
J Goto, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
M Yamashita, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
T Ogura, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
H Makino, Medicine and Clinical Science, Okayama University Graduate School, Okayama, Japan
H Doihara, Cancer and Thoracic Surgery, Okayama University Graduate School, Okayama, Japan

Correspondence: Fumio Otsuka, Email: fumiotsu{at}md.okayama-u.ac.jp

Abstract

Estrogen is involved in the development and progression of breast cancer. Here we investigated the effects of BMP on breast cancer cell proliferation caused by estrogen using human MCF-7 cells. MCF-7 cells express ERalpha/beta, BMPR and Smads. Estradiol and membrane-impermeable estradiol stimulated MCF-7 cell proliferation. Estradiol also reduced mRNA levels of ERalpha, aromatase and steroid sulfatase. Treatment with BMP/activin had no effects on MCF-7 cell proliferation. However, BMP/activin suppressed estradiol-induced cell mitosis, with the effects of BMP-6/7 and activin being more prominent than those of BMP-2/4. Activin decreased ERalpha mRNA expression, while BMP-6/7 impaired steroid sulfatase expression in MCF-7 cells. Interestingly, Smad1,5,8 activation elicited by BMP-6/7, but not by BMP-2/4, was preserved even under the exposure of high concentration of estradiol. The difference of BMP responsiveness was likely due to the differential modulation of BMPR expression induced by estradiol. In this regard, estradiol decreased the expression levels of ALK-3, 6, ActRII and ActRIIB but did not affect ALK-2 and BMPRII, leading to the sustained effects of BMP-6/7 in estrogen-treated MCF-7 cells. Estradiol rapidly activated MAPK phosphorylation including ERK1/ERK2, p38 and SAPK/JNK pathways and BMP-6/7 and activin preferentially inhibited estraidol-induced p38 phosphorylation. SB203580, a selective p38 MAPK inhibitor effectively suppressed estradiol-induced cell mitosis, suggesting that p38 MAPK plays a key role in estrogen-sensitive breast cancer cell proliferation. Thus, a novel interrelationship between estrogen and the breast cancer BMP system was uncovered, in which inhibitory effects of BMP-6/7 on p38 signaling and steroid sulfatase expression were functionally involved in the suppression of estrogen-induced mitosis of breast cancer cells.




This article has been cited by other articles:


Home page
J EndocrinolHome page
H. Otani, F. Otsuka, M. Takeda, T. Mukai, T. Terasaka, T. Miyoshi, K. Inagaki, J. Suzuki, T. Ogura, M. A Lawson, et al.
Regulation of GNRH production by estrogen and bone morphogenetic proteins in GT1-7 hypothalamic cells
J. Endocrinol., October 1, 2009; 203(1): 87 - 97.
[Abstract] [Full Text] [PDF]


Home page
Cancer Genomics ProteomicsHome page
S. M. BOKOBZA, L. YE, H. E. KYNASTON, R. E. MANSEL, and W. G. JIANG
Reduced Expression of BMPR-IB Correlates with Poor Prognosis and Increased Proliferation of Breast Cancer Cells
Cancer Genomics Proteomics, March 1, 2009; 6(2): 101 - 108.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.